T1	intervention 0 10	Lisinopril
T2	intervention 14 22	Coreg CR
T3	condition 35 49	cardiotoxicity
T4	eligibility 53 99	women with breast cancer receiving trastuzumab
T5	outcome-Measure 1101 1142	comparison of incidence of cardiotoxicity
T6	outcome-Measure 1151 1169	comparison of LVEF
T7	No-of-participants 1430 1433	468
